Global Cell and Gene Therapy CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Cell and Gene Therapy CDMO market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Cell and Gene Therapy CDMO industry chain, the market status of Pharmaceutical Company (Clinical Trial Material CDMOs, Development and Manufacturing CDMOs), Biotechnology Company (Clinical Trial Material CDMOs, Development and Manufacturing CDMOs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy CDMO.
Regionally, the report analyzes the Cell and Gene Therapy CDMO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy CDMO market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cell and Gene Therapy CDMO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy CDMO industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Clinical Trial Material CDMOs, Development and Manufacturing CDMOs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy CDMO market.
Regional Analysis: The report involves examining the Cell and Gene Therapy CDMO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy CDMO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cell and Gene Therapy CDMO:
Company Analysis: Report covers individual Cell and Gene Therapy CDMO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell and Gene Therapy CDMO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Company, Biotechnology Company).
Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy CDMO. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy CDMO areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy CDMO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cell and Gene Therapy CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Cell and Gene Therapy CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy CDMO, with revenue, gross margin and global market share of Cell and Gene Therapy CDMO from 2018 to 2023.
Chapter 3, the Cell and Gene Therapy CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy CDMO.
Chapter 13, to describe Cell and Gene Therapy CDMO research findings and conclusion.
The Global Info Research report includes an overview of the development of the Cell and Gene Therapy CDMO industry chain, the market status of Pharmaceutical Company (Clinical Trial Material CDMOs, Development and Manufacturing CDMOs), Biotechnology Company (Clinical Trial Material CDMOs, Development and Manufacturing CDMOs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy CDMO.
Regionally, the report analyzes the Cell and Gene Therapy CDMO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy CDMO market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cell and Gene Therapy CDMO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy CDMO industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Clinical Trial Material CDMOs, Development and Manufacturing CDMOs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy CDMO market.
Regional Analysis: The report involves examining the Cell and Gene Therapy CDMO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy CDMO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cell and Gene Therapy CDMO:
Company Analysis: Report covers individual Cell and Gene Therapy CDMO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell and Gene Therapy CDMO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Company, Biotechnology Company).
Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy CDMO. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy CDMO areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy CDMO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cell and Gene Therapy CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Clinical Trial Material CDMOs
- Development and Manufacturing CDMOs
- Other
- Pharmaceutical Company
- Biotechnology Company
- Other
- Lonza
- Charles River Laboratories
- Cytiva
- Catalent Biologics
- FUJIFILM Diosynth Biotechnologies
- BioCentriq
- RoslinCT
- Thermo Scientific
- Mesoblast
- Cellularity
- Bluebird Bio
- Editas Medicine
- Andelyn Biosciences
- Wuxi Advanced Therapies
- AGC Biologics
- Pfizer CentreOne
- Almac Group
- PCI Pharma Services
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Cell and Gene Therapy CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy CDMO, with revenue, gross margin and global market share of Cell and Gene Therapy CDMO from 2018 to 2023.
Chapter 3, the Cell and Gene Therapy CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy CDMO.
Chapter 13, to describe Cell and Gene Therapy CDMO research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cell and Gene Therapy CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy CDMO by Type
1.3.1 Overview: Global Cell and Gene Therapy CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cell and Gene Therapy CDMO Consumption Value Market Share by Type in 2022
1.3.3 Clinical Trial Material CDMOs
1.3.4 Development and Manufacturing CDMOs
1.3.5 Other
1.4 Global Cell and Gene Therapy CDMO Market by Application
1.4.1 Overview: Global Cell and Gene Therapy CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.4.4 Other
1.5 Global Cell and Gene Therapy CDMO Market Size & Forecast
1.6 Global Cell and Gene Therapy CDMO Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cell and Gene Therapy CDMO Market Size by Region, (2018-2029)
1.6.3 North America Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Cell and Gene Therapy CDMO Product and Solutions
2.1.4 Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Charles River Laboratories
2.2.1 Charles River Laboratories Details
2.2.2 Charles River Laboratories Major Business
2.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Product and Solutions
2.2.4 Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Charles River Laboratories Recent Developments and Future Plans
2.3 Cytiva
2.3.1 Cytiva Details
2.3.2 Cytiva Major Business
2.3.3 Cytiva Cell and Gene Therapy CDMO Product and Solutions
2.3.4 Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cytiva Recent Developments and Future Plans
2.4 Catalent Biologics
2.4.1 Catalent Biologics Details
2.4.2 Catalent Biologics Major Business
2.4.3 Catalent Biologics Cell and Gene Therapy CDMO Product and Solutions
2.4.4 Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Catalent Biologics Recent Developments and Future Plans
2.5 FUJIFILM Diosynth Biotechnologies
2.5.1 FUJIFILM Diosynth Biotechnologies Details
2.5.2 FUJIFILM Diosynth Biotechnologies Major Business
2.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product and Solutions
2.5.4 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.6 BioCentriq
2.6.1 BioCentriq Details
2.6.2 BioCentriq Major Business
2.6.3 BioCentriq Cell and Gene Therapy CDMO Product and Solutions
2.6.4 BioCentriq Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BioCentriq Recent Developments and Future Plans
2.7 RoslinCT
2.7.1 RoslinCT Details
2.7.2 RoslinCT Major Business
2.7.3 RoslinCT Cell and Gene Therapy CDMO Product and Solutions
2.7.4 RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 RoslinCT Recent Developments and Future Plans
2.8 Thermo Scientific
2.8.1 Thermo Scientific Details
2.8.2 Thermo Scientific Major Business
2.8.3 Thermo Scientific Cell and Gene Therapy CDMO Product and Solutions
2.8.4 Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Thermo Scientific Recent Developments and Future Plans
2.9 Mesoblast
2.9.1 Mesoblast Details
2.9.2 Mesoblast Major Business
2.9.3 Mesoblast Cell and Gene Therapy CDMO Product and Solutions
2.9.4 Mesoblast Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mesoblast Recent Developments and Future Plans
2.10 Cellularity
2.10.1 Cellularity Details
2.10.2 Cellularity Major Business
2.10.3 Cellularity Cell and Gene Therapy CDMO Product and Solutions
2.10.4 Cellularity Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cellularity Recent Developments and Future Plans
2.11 Bluebird Bio
2.11.1 Bluebird Bio Details
2.11.2 Bluebird Bio Major Business
2.11.3 Bluebird Bio Cell and Gene Therapy CDMO Product and Solutions
2.11.4 Bluebird Bio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bluebird Bio Recent Developments and Future Plans
2.12 Editas Medicine
2.12.1 Editas Medicine Details
2.12.2 Editas Medicine Major Business
2.12.3 Editas Medicine Cell and Gene Therapy CDMO Product and Solutions
2.12.4 Editas Medicine Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Editas Medicine Recent Developments and Future Plans
2.13 Andelyn Biosciences
2.13.1 Andelyn Biosciences Details
2.13.2 Andelyn Biosciences Major Business
2.13.3 Andelyn Biosciences Cell and Gene Therapy CDMO Product and Solutions
2.13.4 Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Andelyn Biosciences Recent Developments and Future Plans
2.14 Wuxi Advanced Therapies
2.14.1 Wuxi Advanced Therapies Details
2.14.2 Wuxi Advanced Therapies Major Business
2.14.3 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product and Solutions
2.14.4 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Wuxi Advanced Therapies Recent Developments and Future Plans
2.15 AGC Biologics
2.15.1 AGC Biologics Details
2.15.2 AGC Biologics Major Business
2.15.3 AGC Biologics Cell and Gene Therapy CDMO Product and Solutions
2.15.4 AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 AGC Biologics Recent Developments and Future Plans
2.16 Pfizer CentreOne
2.16.1 Pfizer CentreOne Details
2.16.2 Pfizer CentreOne Major Business
2.16.3 Pfizer CentreOne Cell and Gene Therapy CDMO Product and Solutions
2.16.4 Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Pfizer CentreOne Recent Developments and Future Plans
2.17 Almac Group
2.17.1 Almac Group Details
2.17.2 Almac Group Major Business
2.17.3 Almac Group Cell and Gene Therapy CDMO Product and Solutions
2.17.4 Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Almac Group Recent Developments and Future Plans
2.18 PCI Pharma Services
2.18.1 PCI Pharma Services Details
2.18.2 PCI Pharma Services Major Business
2.18.3 PCI Pharma Services Cell and Gene Therapy CDMO Product and Solutions
2.18.4 PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 PCI Pharma Services Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell and Gene Therapy CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cell and Gene Therapy CDMO by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy CDMO Players Market Share in 2022
3.2.3 Top 6 Cell and Gene Therapy CDMO Players Market Share in 2022
3.3 Cell and Gene Therapy CDMO Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy CDMO Market: Region Footprint
3.3.2 Cell and Gene Therapy CDMO Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell and Gene Therapy CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cell and Gene Therapy CDMO Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Cell and Gene Therapy CDMO Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
6.2 North America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
6.3 North America Cell and Gene Therapy CDMO Market Size by Country
6.3.1 North America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
7.2 Europe Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
7.3 Europe Cell and Gene Therapy CDMO Market Size by Country
7.3.1 Europe Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
7.3.3 France Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cell and Gene Therapy CDMO Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Region (2018-2029)
8.3.2 China Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8.3.5 India Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
9.2 South America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
9.3 South America Cell and Gene Therapy CDMO Market Size by Country
9.3.1 South America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Cell and Gene Therapy CDMO Market Drivers
11.2 Cell and Gene Therapy CDMO Market Restraints
11.3 Cell and Gene Therapy CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell and Gene Therapy CDMO Industry Chain
12.2 Cell and Gene Therapy CDMO Upstream Analysis
12.3 Cell and Gene Therapy CDMO Midstream Analysis
12.4 Cell and Gene Therapy CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Cell and Gene Therapy CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy CDMO by Type
1.3.1 Overview: Global Cell and Gene Therapy CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cell and Gene Therapy CDMO Consumption Value Market Share by Type in 2022
1.3.3 Clinical Trial Material CDMOs
1.3.4 Development and Manufacturing CDMOs
1.3.5 Other
1.4 Global Cell and Gene Therapy CDMO Market by Application
1.4.1 Overview: Global Cell and Gene Therapy CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.4.4 Other
1.5 Global Cell and Gene Therapy CDMO Market Size & Forecast
1.6 Global Cell and Gene Therapy CDMO Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cell and Gene Therapy CDMO Market Size by Region, (2018-2029)
1.6.3 North America Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Cell and Gene Therapy CDMO Product and Solutions
2.1.4 Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Charles River Laboratories
2.2.1 Charles River Laboratories Details
2.2.2 Charles River Laboratories Major Business
2.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Product and Solutions
2.2.4 Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Charles River Laboratories Recent Developments and Future Plans
2.3 Cytiva
2.3.1 Cytiva Details
2.3.2 Cytiva Major Business
2.3.3 Cytiva Cell and Gene Therapy CDMO Product and Solutions
2.3.4 Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cytiva Recent Developments and Future Plans
2.4 Catalent Biologics
2.4.1 Catalent Biologics Details
2.4.2 Catalent Biologics Major Business
2.4.3 Catalent Biologics Cell and Gene Therapy CDMO Product and Solutions
2.4.4 Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Catalent Biologics Recent Developments and Future Plans
2.5 FUJIFILM Diosynth Biotechnologies
2.5.1 FUJIFILM Diosynth Biotechnologies Details
2.5.2 FUJIFILM Diosynth Biotechnologies Major Business
2.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product and Solutions
2.5.4 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.6 BioCentriq
2.6.1 BioCentriq Details
2.6.2 BioCentriq Major Business
2.6.3 BioCentriq Cell and Gene Therapy CDMO Product and Solutions
2.6.4 BioCentriq Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BioCentriq Recent Developments and Future Plans
2.7 RoslinCT
2.7.1 RoslinCT Details
2.7.2 RoslinCT Major Business
2.7.3 RoslinCT Cell and Gene Therapy CDMO Product and Solutions
2.7.4 RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 RoslinCT Recent Developments and Future Plans
2.8 Thermo Scientific
2.8.1 Thermo Scientific Details
2.8.2 Thermo Scientific Major Business
2.8.3 Thermo Scientific Cell and Gene Therapy CDMO Product and Solutions
2.8.4 Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Thermo Scientific Recent Developments and Future Plans
2.9 Mesoblast
2.9.1 Mesoblast Details
2.9.2 Mesoblast Major Business
2.9.3 Mesoblast Cell and Gene Therapy CDMO Product and Solutions
2.9.4 Mesoblast Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mesoblast Recent Developments and Future Plans
2.10 Cellularity
2.10.1 Cellularity Details
2.10.2 Cellularity Major Business
2.10.3 Cellularity Cell and Gene Therapy CDMO Product and Solutions
2.10.4 Cellularity Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cellularity Recent Developments and Future Plans
2.11 Bluebird Bio
2.11.1 Bluebird Bio Details
2.11.2 Bluebird Bio Major Business
2.11.3 Bluebird Bio Cell and Gene Therapy CDMO Product and Solutions
2.11.4 Bluebird Bio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bluebird Bio Recent Developments and Future Plans
2.12 Editas Medicine
2.12.1 Editas Medicine Details
2.12.2 Editas Medicine Major Business
2.12.3 Editas Medicine Cell and Gene Therapy CDMO Product and Solutions
2.12.4 Editas Medicine Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Editas Medicine Recent Developments and Future Plans
2.13 Andelyn Biosciences
2.13.1 Andelyn Biosciences Details
2.13.2 Andelyn Biosciences Major Business
2.13.3 Andelyn Biosciences Cell and Gene Therapy CDMO Product and Solutions
2.13.4 Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Andelyn Biosciences Recent Developments and Future Plans
2.14 Wuxi Advanced Therapies
2.14.1 Wuxi Advanced Therapies Details
2.14.2 Wuxi Advanced Therapies Major Business
2.14.3 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product and Solutions
2.14.4 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Wuxi Advanced Therapies Recent Developments and Future Plans
2.15 AGC Biologics
2.15.1 AGC Biologics Details
2.15.2 AGC Biologics Major Business
2.15.3 AGC Biologics Cell and Gene Therapy CDMO Product and Solutions
2.15.4 AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 AGC Biologics Recent Developments and Future Plans
2.16 Pfizer CentreOne
2.16.1 Pfizer CentreOne Details
2.16.2 Pfizer CentreOne Major Business
2.16.3 Pfizer CentreOne Cell and Gene Therapy CDMO Product and Solutions
2.16.4 Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Pfizer CentreOne Recent Developments and Future Plans
2.17 Almac Group
2.17.1 Almac Group Details
2.17.2 Almac Group Major Business
2.17.3 Almac Group Cell and Gene Therapy CDMO Product and Solutions
2.17.4 Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Almac Group Recent Developments and Future Plans
2.18 PCI Pharma Services
2.18.1 PCI Pharma Services Details
2.18.2 PCI Pharma Services Major Business
2.18.3 PCI Pharma Services Cell and Gene Therapy CDMO Product and Solutions
2.18.4 PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 PCI Pharma Services Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell and Gene Therapy CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cell and Gene Therapy CDMO by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy CDMO Players Market Share in 2022
3.2.3 Top 6 Cell and Gene Therapy CDMO Players Market Share in 2022
3.3 Cell and Gene Therapy CDMO Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy CDMO Market: Region Footprint
3.3.2 Cell and Gene Therapy CDMO Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell and Gene Therapy CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cell and Gene Therapy CDMO Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Cell and Gene Therapy CDMO Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
6.2 North America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
6.3 North America Cell and Gene Therapy CDMO Market Size by Country
6.3.1 North America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
7.2 Europe Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
7.3 Europe Cell and Gene Therapy CDMO Market Size by Country
7.3.1 Europe Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
7.3.3 France Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cell and Gene Therapy CDMO Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Region (2018-2029)
8.3.2 China Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8.3.5 India Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
9.2 South America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
9.3 South America Cell and Gene Therapy CDMO Market Size by Country
9.3.1 South America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Cell and Gene Therapy CDMO Market Drivers
11.2 Cell and Gene Therapy CDMO Market Restraints
11.3 Cell and Gene Therapy CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell and Gene Therapy CDMO Industry Chain
12.2 Cell and Gene Therapy CDMO Upstream Analysis
12.3 Cell and Gene Therapy CDMO Midstream Analysis
12.4 Cell and Gene Therapy CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cell and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cell and Gene Therapy CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cell and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cell and Gene Therapy CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Lonza Company Information, Head Office, and Major Competitors
Table 6. Lonza Major Business
Table 7. Lonza Cell and Gene Therapy CDMO Product and Solutions
Table 8. Lonza Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Lonza Recent Developments and Future Plans
Table 10. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 11. Charles River Laboratories Major Business
Table 12. Charles River Laboratories Cell and Gene Therapy CDMO Product and Solutions
Table 13. Charles River Laboratories Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Charles River Laboratories Recent Developments and Future Plans
Table 15. Cytiva Company Information, Head Office, and Major Competitors
Table 16. Cytiva Major Business
Table 17. Cytiva Cell and Gene Therapy CDMO Product and Solutions
Table 18. Cytiva Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Cytiva Recent Developments and Future Plans
Table 20. Catalent Biologics Company Information, Head Office, and Major Competitors
Table 21. Catalent Biologics Major Business
Table 22. Catalent Biologics Cell and Gene Therapy CDMO Product and Solutions
Table 23. Catalent Biologics Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Catalent Biologics Recent Developments and Future Plans
Table 25. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 26. FUJIFILM Diosynth Biotechnologies Major Business
Table 27. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product and Solutions
Table 28. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 30. BioCentriq Company Information, Head Office, and Major Competitors
Table 31. BioCentriq Major Business
Table 32. BioCentriq Cell and Gene Therapy CDMO Product and Solutions
Table 33. BioCentriq Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. BioCentriq Recent Developments and Future Plans
Table 35. RoslinCT Company Information, Head Office, and Major Competitors
Table 36. RoslinCT Major Business
Table 37. RoslinCT Cell and Gene Therapy CDMO Product and Solutions
Table 38. RoslinCT Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. RoslinCT Recent Developments and Future Plans
Table 40. Thermo Scientific Company Information, Head Office, and Major Competitors
Table 41. Thermo Scientific Major Business
Table 42. Thermo Scientific Cell and Gene Therapy CDMO Product and Solutions
Table 43. Thermo Scientific Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Thermo Scientific Recent Developments and Future Plans
Table 45. Mesoblast Company Information, Head Office, and Major Competitors
Table 46. Mesoblast Major Business
Table 47. Mesoblast Cell and Gene Therapy CDMO Product and Solutions
Table 48. Mesoblast Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Mesoblast Recent Developments and Future Plans
Table 50. Cellularity Company Information, Head Office, and Major Competitors
Table 51. Cellularity Major Business
Table 52. Cellularity Cell and Gene Therapy CDMO Product and Solutions
Table 53. Cellularity Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Cellularity Recent Developments and Future Plans
Table 55. Bluebird Bio Company Information, Head Office, and Major Competitors
Table 56. Bluebird Bio Major Business
Table 57. Bluebird Bio Cell and Gene Therapy CDMO Product and Solutions
Table 58. Bluebird Bio Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Bluebird Bio Recent Developments and Future Plans
Table 60. Editas Medicine Company Information, Head Office, and Major Competitors
Table 61. Editas Medicine Major Business
Table 62. Editas Medicine Cell and Gene Therapy CDMO Product and Solutions
Table 63. Editas Medicine Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Editas Medicine Recent Developments and Future Plans
Table 65. Andelyn Biosciences Company Information, Head Office, and Major Competitors
Table 66. Andelyn Biosciences Major Business
Table 67. Andelyn Biosciences Cell and Gene Therapy CDMO Product and Solutions
Table 68. Andelyn Biosciences Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Andelyn Biosciences Recent Developments and Future Plans
Table 70. Wuxi Advanced Therapies Company Information, Head Office, and Major Competitors
Table 71. Wuxi Advanced Therapies Major Business
Table 72. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product and Solutions
Table 73. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Wuxi Advanced Therapies Recent Developments and Future Plans
Table 75. AGC Biologics Company Information, Head Office, and Major Competitors
Table 76. AGC Biologics Major Business
Table 77. AGC Biologics Cell and Gene Therapy CDMO Product and Solutions
Table 78. AGC Biologics Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. AGC Biologics Recent Developments and Future Plans
Table 80. Pfizer CentreOne Company Information, Head Office, and Major Competitors
Table 81. Pfizer CentreOne Major Business
Table 82. Pfizer CentreOne Cell and Gene Therapy CDMO Product and Solutions
Table 83. Pfizer CentreOne Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Pfizer CentreOne Recent Developments and Future Plans
Table 85. Almac Group Company Information, Head Office, and Major Competitors
Table 86. Almac Group Major Business
Table 87. Almac Group Cell and Gene Therapy CDMO Product and Solutions
Table 88. Almac Group Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Almac Group Recent Developments and Future Plans
Table 90. PCI Pharma Services Company Information, Head Office, and Major Competitors
Table 91. PCI Pharma Services Major Business
Table 92. PCI Pharma Services Cell and Gene Therapy CDMO Product and Solutions
Table 93. PCI Pharma Services Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. PCI Pharma Services Recent Developments and Future Plans
Table 95. Global Cell and Gene Therapy CDMO Revenue (USD Million) by Players (2018-2023)
Table 96. Global Cell and Gene Therapy CDMO Revenue Share by Players (2018-2023)
Table 97. Breakdown of Cell and Gene Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Cell and Gene Therapy CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Cell and Gene Therapy CDMO Players
Table 100. Cell and Gene Therapy CDMO Market: Company Product Type Footprint
Table 101. Cell and Gene Therapy CDMO Market: Company Product Application Footprint
Table 102. Cell and Gene Therapy CDMO New Market Entrants and Barriers to Market Entry
Table 103. Cell and Gene Therapy CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Cell and Gene Therapy CDMO Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Cell and Gene Therapy CDMO Consumption Value Share by Type (2018-2023)
Table 106. Global Cell and Gene Therapy CDMO Consumption Value Forecast by Type (2024-2029)
Table 107. Global Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023)
Table 108. Global Cell and Gene Therapy CDMO Consumption Value Forecast by Application (2024-2029)
Table 109. North America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Cell and Gene Therapy CDMO Raw Material
Table 140. Key Suppliers of Cell and Gene Therapy CDMO Raw Materials
Table 1. Global Cell and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cell and Gene Therapy CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cell and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cell and Gene Therapy CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Lonza Company Information, Head Office, and Major Competitors
Table 6. Lonza Major Business
Table 7. Lonza Cell and Gene Therapy CDMO Product and Solutions
Table 8. Lonza Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Lonza Recent Developments and Future Plans
Table 10. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 11. Charles River Laboratories Major Business
Table 12. Charles River Laboratories Cell and Gene Therapy CDMO Product and Solutions
Table 13. Charles River Laboratories Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Charles River Laboratories Recent Developments and Future Plans
Table 15. Cytiva Company Information, Head Office, and Major Competitors
Table 16. Cytiva Major Business
Table 17. Cytiva Cell and Gene Therapy CDMO Product and Solutions
Table 18. Cytiva Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Cytiva Recent Developments and Future Plans
Table 20. Catalent Biologics Company Information, Head Office, and Major Competitors
Table 21. Catalent Biologics Major Business
Table 22. Catalent Biologics Cell and Gene Therapy CDMO Product and Solutions
Table 23. Catalent Biologics Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Catalent Biologics Recent Developments and Future Plans
Table 25. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 26. FUJIFILM Diosynth Biotechnologies Major Business
Table 27. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product and Solutions
Table 28. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 30. BioCentriq Company Information, Head Office, and Major Competitors
Table 31. BioCentriq Major Business
Table 32. BioCentriq Cell and Gene Therapy CDMO Product and Solutions
Table 33. BioCentriq Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. BioCentriq Recent Developments and Future Plans
Table 35. RoslinCT Company Information, Head Office, and Major Competitors
Table 36. RoslinCT Major Business
Table 37. RoslinCT Cell and Gene Therapy CDMO Product and Solutions
Table 38. RoslinCT Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. RoslinCT Recent Developments and Future Plans
Table 40. Thermo Scientific Company Information, Head Office, and Major Competitors
Table 41. Thermo Scientific Major Business
Table 42. Thermo Scientific Cell and Gene Therapy CDMO Product and Solutions
Table 43. Thermo Scientific Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Thermo Scientific Recent Developments and Future Plans
Table 45. Mesoblast Company Information, Head Office, and Major Competitors
Table 46. Mesoblast Major Business
Table 47. Mesoblast Cell and Gene Therapy CDMO Product and Solutions
Table 48. Mesoblast Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Mesoblast Recent Developments and Future Plans
Table 50. Cellularity Company Information, Head Office, and Major Competitors
Table 51. Cellularity Major Business
Table 52. Cellularity Cell and Gene Therapy CDMO Product and Solutions
Table 53. Cellularity Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Cellularity Recent Developments and Future Plans
Table 55. Bluebird Bio Company Information, Head Office, and Major Competitors
Table 56. Bluebird Bio Major Business
Table 57. Bluebird Bio Cell and Gene Therapy CDMO Product and Solutions
Table 58. Bluebird Bio Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Bluebird Bio Recent Developments and Future Plans
Table 60. Editas Medicine Company Information, Head Office, and Major Competitors
Table 61. Editas Medicine Major Business
Table 62. Editas Medicine Cell and Gene Therapy CDMO Product and Solutions
Table 63. Editas Medicine Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Editas Medicine Recent Developments and Future Plans
Table 65. Andelyn Biosciences Company Information, Head Office, and Major Competitors
Table 66. Andelyn Biosciences Major Business
Table 67. Andelyn Biosciences Cell and Gene Therapy CDMO Product and Solutions
Table 68. Andelyn Biosciences Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Andelyn Biosciences Recent Developments and Future Plans
Table 70. Wuxi Advanced Therapies Company Information, Head Office, and Major Competitors
Table 71. Wuxi Advanced Therapies Major Business
Table 72. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product and Solutions
Table 73. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Wuxi Advanced Therapies Recent Developments and Future Plans
Table 75. AGC Biologics Company Information, Head Office, and Major Competitors
Table 76. AGC Biologics Major Business
Table 77. AGC Biologics Cell and Gene Therapy CDMO Product and Solutions
Table 78. AGC Biologics Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. AGC Biologics Recent Developments and Future Plans
Table 80. Pfizer CentreOne Company Information, Head Office, and Major Competitors
Table 81. Pfizer CentreOne Major Business
Table 82. Pfizer CentreOne Cell and Gene Therapy CDMO Product and Solutions
Table 83. Pfizer CentreOne Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Pfizer CentreOne Recent Developments and Future Plans
Table 85. Almac Group Company Information, Head Office, and Major Competitors
Table 86. Almac Group Major Business
Table 87. Almac Group Cell and Gene Therapy CDMO Product and Solutions
Table 88. Almac Group Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Almac Group Recent Developments and Future Plans
Table 90. PCI Pharma Services Company Information, Head Office, and Major Competitors
Table 91. PCI Pharma Services Major Business
Table 92. PCI Pharma Services Cell and Gene Therapy CDMO Product and Solutions
Table 93. PCI Pharma Services Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. PCI Pharma Services Recent Developments and Future Plans
Table 95. Global Cell and Gene Therapy CDMO Revenue (USD Million) by Players (2018-2023)
Table 96. Global Cell and Gene Therapy CDMO Revenue Share by Players (2018-2023)
Table 97. Breakdown of Cell and Gene Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Cell and Gene Therapy CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Cell and Gene Therapy CDMO Players
Table 100. Cell and Gene Therapy CDMO Market: Company Product Type Footprint
Table 101. Cell and Gene Therapy CDMO Market: Company Product Application Footprint
Table 102. Cell and Gene Therapy CDMO New Market Entrants and Barriers to Market Entry
Table 103. Cell and Gene Therapy CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Cell and Gene Therapy CDMO Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Cell and Gene Therapy CDMO Consumption Value Share by Type (2018-2023)
Table 106. Global Cell and Gene Therapy CDMO Consumption Value Forecast by Type (2024-2029)
Table 107. Global Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023)
Table 108. Global Cell and Gene Therapy CDMO Consumption Value Forecast by Application (2024-2029)
Table 109. North America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Cell and Gene Therapy CDMO Raw Material
Table 140. Key Suppliers of Cell and Gene Therapy CDMO Raw Materials
LIST OF FIGURES
Figure 1. Cell and Gene Therapy CDMO Picture
Figure 2. Global Cell and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cell and Gene Therapy CDMO Consumption Value Market Share by Type in 2022
Figure 4. Clinical Trial Material CDMOs
Figure 5. Development and Manufacturing CDMOs
Figure 6. Other
Figure 7. Global Cell and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Cell and Gene Therapy CDMO Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical Company Picture
Figure 10. Biotechnology Company Picture
Figure 11. Other Picture
Figure 12. Global Cell and Gene Therapy CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Cell and Gene Therapy CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Cell and Gene Therapy CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Cell and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Cell and Gene Therapy CDMO Consumption Value Market Share by Region in 2022
Figure 17. North America Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Cell and Gene Therapy CDMO Revenue Share by Players in 2022
Figure 23. Cell and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Cell and Gene Therapy CDMO Market Share in 2022
Figure 25. Global Top 6 Players Cell and Gene Therapy CDMO Market Share in 2022
Figure 26. Global Cell and Gene Therapy CDMO Consumption Value Share by Type (2018-2023)
Figure 27. Global Cell and Gene Therapy CDMO Market Share Forecast by Type (2024-2029)
Figure 28. Global Cell and Gene Therapy CDMO Consumption Value Share by Application (2018-2023)
Figure 29. Global Cell and Gene Therapy CDMO Market Share Forecast by Application (2024-2029)
Figure 30. North America Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 40. France Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
Figure 47. China Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 50. India Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 64. Cell and Gene Therapy CDMO Market Drivers
Figure 65. Cell and Gene Therapy CDMO Market Restraints
Figure 66. Cell and Gene Therapy CDMO Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Cell and Gene Therapy CDMO in 2022
Figure 69. Manufacturing Process Analysis of Cell and Gene Therapy CDMO
Figure 70. Cell and Gene Therapy CDMO Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Cell and Gene Therapy CDMO Picture
Figure 2. Global Cell and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cell and Gene Therapy CDMO Consumption Value Market Share by Type in 2022
Figure 4. Clinical Trial Material CDMOs
Figure 5. Development and Manufacturing CDMOs
Figure 6. Other
Figure 7. Global Cell and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Cell and Gene Therapy CDMO Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical Company Picture
Figure 10. Biotechnology Company Picture
Figure 11. Other Picture
Figure 12. Global Cell and Gene Therapy CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Cell and Gene Therapy CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Cell and Gene Therapy CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Cell and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Cell and Gene Therapy CDMO Consumption Value Market Share by Region in 2022
Figure 17. North America Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Cell and Gene Therapy CDMO Revenue Share by Players in 2022
Figure 23. Cell and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Cell and Gene Therapy CDMO Market Share in 2022
Figure 25. Global Top 6 Players Cell and Gene Therapy CDMO Market Share in 2022
Figure 26. Global Cell and Gene Therapy CDMO Consumption Value Share by Type (2018-2023)
Figure 27. Global Cell and Gene Therapy CDMO Market Share Forecast by Type (2024-2029)
Figure 28. Global Cell and Gene Therapy CDMO Consumption Value Share by Application (2018-2023)
Figure 29. Global Cell and Gene Therapy CDMO Market Share Forecast by Application (2024-2029)
Figure 30. North America Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 40. France Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
Figure 47. China Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 50. India Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 64. Cell and Gene Therapy CDMO Market Drivers
Figure 65. Cell and Gene Therapy CDMO Market Restraints
Figure 66. Cell and Gene Therapy CDMO Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Cell and Gene Therapy CDMO in 2022
Figure 69. Manufacturing Process Analysis of Cell and Gene Therapy CDMO
Figure 70. Cell and Gene Therapy CDMO Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
